
A randomized controlled trial evaluated intratympanic sodium thiosulfate (STS) gel for preventing cisplatin-induced hearing loss in adults with head and neck cancer. Although STS did not significantly reduce overall ototoxicity incidence, treated ears showed smaller hearing threshold shifts at several high and extended-high frequencies.
Like
Save
Share